According to Rasna Therapeutics latest financial reports the cash on hand of RASP is $74.99K, an increase of 90.50% to 2022. At the end of 2022 company had $39.36K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $74.99K | 90.50% |
2022 | $39.36K | 262.86% |
2021 | $10.85K | -23.83% |
2020 | $14.24K | -71.56% |
2019 | $50.07K | 17.27% |
2018 | $42.69K | - |